Classical swine fever

Lore & Background

Classical swine fever, also known as hog cholera, is a highly contagious viral disease affecting both Old World and New World pigs. The causative agent is a virus of the genus *Orthopestivirus*, closely related to those causing bovine viral diarrhea and border disease in ruminants. The disease manifests in acute and chronic forms, with severity ranging from mild or unapparent infections to severe cases with high mortality. In its acute form, infected animals develop fever, huddle together, lose appetite, and show weakness, conjunctivitis, and an unsteady gait, with constipation followed by diarrhea. A purple discoloration often appears on the ears, abdomen, and inner thighs. Death typically occurs within one to two weeks, and severe cases closely resemble African swine fever. Less virulent strains may cause only poor reproductive performance or congenital tremor in newborn piglets. The incubation period spans two to fourteen days, though clinical signs may not appear for up to three weeks. Infected piglets born to apparently healthy sows can maintain the disease within a population. The virus can cause pinpoint hemorrhages on the kidneys, and histological examination of the brain may reveal vasculoendothelial proliferation and perivascular cuffing. The disease is endemic across much of Asia, Central and South America, and parts of Europe and Africa, with wild boar and feral pig populations serving as reservoirs. Eradication efforts rely on rapid detection, diagnosis, and slaughter, sometimes supplemented by emergency vaccination.

Reader's Guide

Classical swine fever, also known as hog cholera, is a highly contagious viral disease affecting both Old World and New World pigs. The causative agent, CSFV, belongs to the genus *Orthopestivirus* and is closely related to the viruses responsible for bovine viral diarrhea and border disease in ruminants. The disease manifests in acute and chronic forms, with severity ranging from high mortality to mild or unapparent infections. Acute cases present with fever, loss of appetite, weakness, conjunctivitis, constipation followed by diarrhea, and an unsteady gait; a purple discoloration of the ears, abdomen, and inner thighs may appear days later, with death typically occurring within one to two weeks. Severe cases closely resemble African swine fever. Low-virulence strains may only cause poor reproductive performance or neurologic defects like congenital tremor in newborn piglets. The incubation period ranges from two to fourteen days, though clinical signs may not appear for two to three weeks; infected animals can survive two to three months before death. A small fraction of infected pigs survive and become immune, and artificial immunization was first developed by Marion Dorset. The disease is endemic across much of Asia, Central and South America, and parts of Europe and Africa. It was eradicated in the United Kingdom by 1966, though an outbreak occurred in East Anglia in 2000, and the United States was declared free of the disease in 1978. Outbreaks in Italy and Spain were genetically traced to shipments of piglets from the Netherlands. Eradication programs focus on rapid detection, diagnosis, and slaughter, with emergency vaccination used where the virus is widespread in domestic or wild pigs. In the European Union, hunting restrictions and marker vaccines help control spread in wild boar. The virus has been mentioned as a potential bioweapon.

Did You Know?

• A small fraction of infected pigs may survive and become immune; artificial immunization was first developed by Marion Dorset.
• The incubation period ranges from 2 to 14 days, but clinical signs may not appear until 2 to 3 weeks; regulations assume 21 days as the outside limit.
• Infected piglets born to subclinical sows help maintain the disease within a population.

Virological Origins and the Spillover Question

The 2009 pandemic strain emerged from a complex genetic history. It was not a simple mutation but the product of a triple reassortment event in which bird, swine, and human influenza lineages merged, and that hybrid then combined again with a Eurasian pig flu virus. This layered origin is what gave the pathogen its "swine flu" label. Genetic divergence analysis of early samples pointed to the virus having crossed into humans sometime between June and late November 2008, with September being the most likely window. Crucially, the virus had been circulating silently in pig populations for months before the first human cases surfaced, a finding that underscored the importance of agricultural surveillance. The geographic origin remained contested: U.S. agricultural officials in 2009 floated the idea that the virus may have emerged in Asian pigs and hitched a ride to North America on a human traveler, though they stressed this was unprovable. A 2016 Mount Sinai School of Medicine report, however, narrowed the likely birthplace to a small region of central Mexico, where the virus had been latent in local pig herds before its eventual spillover.

Clinical Profile and the Pneumonia Warning

One of the most striking features of the 2009 H1N1 pandemic was its unusual demographic footprint. Unlike typical seasonal influenza, which tends to hit older adults hardest, this strain did not disproportionately infect people over sixty. That deviation from the norm made the outbreak particularly unsettling for public health planners who had built their response models around protecting the elderly. Even among previously healthy individuals, a small fraction progressed to pneumonia or acute respiratory distress syndrome, a condition marked by worsening breathing difficulty that typically emerged three to six days after the first flu symptoms appeared. The pneumonia could take two forms: a direct viral infection of the lung tissue, or a secondary bacterial superinfection. A November 2009 article in the New England Journal of Medicine advised that patients whose chest X-rays revealed pneumonia should receive both antiviral and antibiotic therapy. A particularly alarming clinical sign was a child who seemed to be improving and then suddenly relapsed with a high fever, a pattern that often signaled the onset of bacterial pneumonia.

Naming Chaos and the Stigmatization Debate

The naming of the 2009 pandemic became a flashpoint in public communication. Early on, a chaotic patchwork of labels proliferated: "H1N1 flu," "Swine flu," "Mexican flu," and numerous other variants. Critics argued that technical jargon like "H1N1" was impenetrable to the general public, that "swine flu" wrongly suggested the disease spread through contact with pigs, and that "Mexican flu" stigmatized an entire community. Research published in 2013 confirmed that Mexican Americans and Latino Americans did face measurable stigmatization linked to the media's repeated use of that label. Different governments adopted different terms with varying consistency. The Netherlands used "Pig Flu" early in the outbreak. Israel and South Korea briefly considered calling it the "Mexican virus" to avoid the word "swine," driven respectively by religious sensitivities around pork in Jewish and Muslim populations and by the cultural importance of domestic pigs in Korea. The World Organisation for Animal Health proposed "North American influenza," while the European Commission settled on "novel flu virus." The WHO eventually standardized on "A(H1N1)pdm09" in 2010. The sheer volume of competing names was so bewildering that the news desk at Science quipped the swine flu names were evolving faster than the swine flu itself.

True Mortality, Global Scale, and the Narcolepsy Link

The true scale of the 2009 pandemic far exceeded the numbers initially reported. Joint analyses with the U.S. Case counts were similarly undercounted; modeling suggested between 700 million and 1.4 billion people—roughly 11 to 21 percent of the then-6.8 billion global population—were actually infected, including asymptomatic and mild cases. Yet one unexpected long-term consequence emerged: the 2009 H1N1 epidemic was associated with a significant rise in new cases of narcolepsy, adding a new dimension to the pandemic's legacy.